Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher A Maher

Showing results (51-60 of 101) with videos related to

Pageof 11
Sort By:
The Journal of Molecular Diagnostics : JMD|May 13, 2014
cDNA hybrid capture improves transcriptome analysis on low-input and archived samplesChristopher R Cabanski, Vincent Magrini, Malachi Griffith, et al.
Nature Cell Biology|June 13, 2024
Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progressionMeng Zhang, Martin Sjöström, Xiekui Cui, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2021
Phase 1 study combining alisertib with nab-paclitaxel in patients with advanced solid malignanciesKian-Huat Lim, Mateusz Opyrchal, Abhi Acharya, et al.
European Urology|July 28, 2016
Multi-institutional Analysis Shows that Low PCAT-14 Expression Associates with Poor Outcomes in Prostate CancerNicole M White, Shuang G Zhao, Jin Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2019
Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer TypesWilliam S Chen, Mohammed Alshalalfa, Shuang G Zhao, et al.
JCO Precision Oncology|September 9, 2020
Cell-free DNA alterations in the <i>AR</i> enhancer and locus predict resistance to AR-directed therapy in patients with metastatic prostate cancerHa X Dang, Pradeep S Chauhan, Haley Ellis, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2008
Genome-wide analysis of cancer/testis gene expressionOliver Hofmann, Otavia L Caballero, Brian J Stevenson, et al.
The Journal of Cell Biology|October 26, 2011
A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transitionNam Hee Kim, Hyun Sil Kim, Xiao-Yan Li, et al.
NPJ Breast Cancer|December 8, 2017
Genomic and transcriptomic heterogeneity in metaplastic carcinomas of the breastSalvatore Piscuoglio, Charlotte K Y Ng, Felipe C Geyer, et al.
Science (New York, N.Y.)|November 15, 2008
Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancerSooryanarayana Varambally, Qi Cao, Ram-Shankar Mani, et al.
Pageof 11

Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
The Journal of Molecular Diagnostics : JMD|May 13, 2014
cDNA hybrid capture improves transcriptome analysis on low-input and archived samplesChristopher R Cabanski, Vincent Magrini, Malachi Griffith, et al.
Nature Cell Biology|June 13, 2024
Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progressionMeng Zhang, Martin Sjöström, Xiekui Cui, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2021
Phase 1 study combining alisertib with nab-paclitaxel in patients with advanced solid malignanciesKian-Huat Lim, Mateusz Opyrchal, Abhi Acharya, et al.
European Urology|July 28, 2016
Multi-institutional Analysis Shows that Low PCAT-14 Expression Associates with Poor Outcomes in Prostate CancerNicole M White, Shuang G Zhao, Jin Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2019
Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer TypesWilliam S Chen, Mohammed Alshalalfa, Shuang G Zhao, et al.
JCO Precision Oncology|September 9, 2020
Cell-free DNA alterations in the <i>AR</i> enhancer and locus predict resistance to AR-directed therapy in patients with metastatic prostate cancerHa X Dang, Pradeep S Chauhan, Haley Ellis, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2008
Genome-wide analysis of cancer/testis gene expressionOliver Hofmann, Otavia L Caballero, Brian J Stevenson, et al.
The Journal of Cell Biology|October 26, 2011
A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transitionNam Hee Kim, Hyun Sil Kim, Xiao-Yan Li, et al.
NPJ Breast Cancer|December 8, 2017
Genomic and transcriptomic heterogeneity in metaplastic carcinomas of the breastSalvatore Piscuoglio, Charlotte K Y Ng, Felipe C Geyer, et al.
Science (New York, N.Y.)|November 15, 2008
Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancerSooryanarayana Varambally, Qi Cao, Ram-Shankar Mani, et al.
Pageof 11